People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little ...

Increasing numbers of Australians are using medicinal cannabis for anxiety, depression, insomnia, substance disorders and ...

A preclinical study published in Biological Psychiatry has found that repeated low doses of psilocybin and MDMA reshape ...

New research reveals that psilocybin and MDMA promote long-term PTSD recovery by physically remodeling myelin insulation in ...

Could hyperbaric oxygen treat PTSD, depression, and anxiety? New evidence suggests that this treatment may rewire the ...

A landmark Lancet Psychiatry paper published today has found no evidence that medicinal cannabis is effective in treating anxiety, depression or post-traumatic stress disorder (PTSD).

CLEVELAND, Ohio — A study by Ohio State University researchers suggests that adding a stellate ganglion block to cognitive processing therapy (CPT) helps military members and veterans recover from ...

Quitting cannabis may yield greater improvements in PTSD symptoms than continued use in adults with both PTSD and cannabis ...

DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for Patients with Comorbid Alcohol Use Disorder PT150 offers a rare, dual-validated ...

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial Compass continues to advance ...

A sympathetic nerve block that has shown promise for treatment of post-traumatic stress disorder (PTSD) performed no better than sham treatment in a randomized controlled trial, new research shows.

Researchers say they have found physical evidence of PTSD in World Trade Center first responders.